Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
RNACure
RNACure
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
RNACure
RNACure Summary
Company Summary
Overview
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis. It focuses on the mRNA-based vaccines and therapies of severe diseases.
Type
Private
Status
Active
Founded
2019
HQ
Shanghai, CN
|
view all locations
Website
http://rnacure.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
pharma
Homepage
Table of Contents
Key People
Operating Metrics
Locations
Competitors
Key People
Hang Yu,
CEO
Linkedin
Bing Wang,
COO
Jing Lu,
CSO
Operating Metrics
View all
Vaccine Categories
6
May, 2020
Platforms
2
May, 2020
Locations
View all
1 location detected
Shanghai, Shanghai
HQ
China
Competitors and Similar Companies
RNAimmune
Healthcare - Subsidiary
Stemirna
Healthcare - Private
Moderna
Healthcare - Public
Mercurna
Healthcare - Private
CureVac
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top